Skip to content

ARKG ARK ETF TR

Follow

GENOMIC REV ETF (fund)

Filings received so far for Q3 2026: 8 13F filers report a position in ARKG shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Midwest Financial Partners Investments,…205,204$11.1M4.28%-6,18213F-HRTimeline
Client First Investment Management LLC21,953$1.19M0.57%-39,36813F-HRTimeline
Post Resch Tallon Group Inc.21,028$1.14M0.78%-76513F-HRTimeline
TITLEIST ASSET MANAGEMENT, LLC7,100$385K0.02%-1,25013F-HRTimeline
Farther Finance Advisors, LLC1,914$104K<0.01%+34813F-HRTimeline
GK Wealth Management LLC490$26.6K0.01%new13F-HRTimeline
Rosenberg Matthew Hamilton201$10.9K<0.01%new13F-HRTimeline
ARMSTRONG ADVISORY GROUP, INC70$3.8K<0.01%013F-HRTimeline